Liquidity on Layaway: Inside the Continuation Vehicle Boom Reshaping Private Equity's Exit Math
For most of private equity's modern history, the exit was a binary event: sell the company or take it public. Today, a third path has grown so large it rivals both. GP-led secondary transactions — most notably continuation vehicles that roll a single asset or portfolio into a newly sponsored fund — are on pace to clear well over $100 billion annually, and industry estimates peg total secondary market volume above the trillion-dollar mark when LP-led stake sales are included.
The question circulating through LP meetings and conference hallways from New York to San Francisco is no longer whether continuation vehicles matter. It's whether they represent a genuine service to investors or an elaborate mechanism for deferring hard conversations about underperforming assets.
The Mechanics Behind the Growth
A continuation vehicle works like this: a sponsor identifies an asset it isn't ready to sell, contributes it to a new vehicle, and offers existing LPs a choice — take cash now at a negotiated price, or roll their stake into the new entity alongside fresh secondary capital. Pricing is typically set by an independent third-party valuation, though the process varies widely in rigor.
The appeal for GPs is obvious. Traditional exit channels remain clogged. IPO windows have been effectively shuttered for all but the largest issuers, and strategic acquirers have grown selective in a higher-cost-of-capital environment. A continuation vehicle lets a sponsor hold an asset it believes is undervalued by today's buyers while still delivering DPI — distributions to paid-in capital — that LPs increasingly demand.
Who Benefits, and How Much
Defenders of the structure point to legitimate use cases. A sponsor with two years left on a fund life shouldn't be forced to sell a business mid-value-creation plan simply because the clock ran out. Continuation vehicles, in that framing, align the asset's timeline with its actual trajectory.
Critics see something else. Advisory firms that review these transactions on behalf of institutional investors report a persistent pattern: assets rolled into continuation vehicles skew toward those that would otherwise face markdowns. An asset that could fetch a strong price in an open auction rarely needs a continuation vehicle — the sponsor can simply sell it. The structure, skeptics argue, is disproportionately used where the open market won't pay what the GP's model says the business is worth.
There's also the fee question. Sponsors typically earn fresh transaction fees and renewed carry on assets rolled into continuation vehicles, raising the specter of misaligned incentives. A GP who can reset the carry clock on a stale asset has a reason to prefer that route over a clean exit.
The LP's Calculus
For limited partners, the decision at rollout is genuinely difficult. Take the cash and crystallize a price set by a process the GP controls. Roll in, and you're doubling down on an asset — and a manager — at exactly the moment you might prefer diversification. Many institutions, particularly smaller endowments and foundations without dedicated secondary expertise, simply accept the liquidity option without deep analysis.
Sophisticated LPs have responded by building internal review protocols: independent valuation checks, scrutiny of the third-party pricing agent's mandate, and hard questions about why this asset, at this moment. Some have begun negotiating for pro-rata participation rights and enhanced disclosure as a condition of consent.
Toward a Market Standard
The secondary market's growth is not inherently a problem. Liquidity solutions for an illiquid asset class serve a real function, and the best continuation vehicles — those run at fair prices with genuine LP choice — have delivered solid returns for secondary buyers and clean outcomes for exiting LPs.
What the market needs now is standardization. Independent pricing with teeth, aligned fee structures, and transparent disclosure of why an asset is being continued would go a long way toward separating legitimate liquidity solutions from life support for underperformers. LP associations and institutional investors are already pushing in this direction.
The firms that embrace genuine transparency will find LPs more willing to consent — and consent is the whole game. A continuation vehicle without LP support is just a paper structure. In a market where every distribution now gets scrutinized, the sponsors who treat secondaries as a partnership tool rather than a pressure valve will be the ones LPs stick with through the next cycle.
